Diabetes mellitus and impaired pancreatic β-cell proliferation

Journal of Internal Medicine

Volumn 239, Issue 3, 1996, Pages 211-220

  Sjoholm A ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Löwenströmska Hospital   (Sweden)

Author keywords

Diabetes mellitus; Insulin secretion; Insulin synthesis; Pancreatic islets; cell proliferation

Indexed keywords

INSULIN;

CELL PROLIFERATION; CELL REGENERATION; CELL TRANSPLANTATION; DIABETES MELLITUS; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW;

EID: 0030048630     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.377740000.x     Document Type: Review

References (87)

1. Hellerström C, Andersson A, Swenne I, Welsh M, Welsh N, Sjöholm Å. Replication of β-cells in the normal and diabetic pancreas. In: Efendić S, Grill V, eds. Nobel Symposium - Pathogenesis of Non-Insulin Dependent Diabetes Mellitus. New York, NY: Raven Press, 1988; pp. 79-91.
2. Hellerström C. The life story of the pancreatic β-cell. Diabetologia 1984; 26: 393-400.
3. Hellerström C, Swenne I. Growth pattern of pancreatic islets in animals. In: Volk BW, Arquilla ER, eds. The Diabetic Pancreas. New York, NY: Plenum Press, 1985; pp. 55-79.
4. Weir GC, Leahy JL, Bonner-Weir S. Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes. Diabetes/Metabolism Rev 1986; 2: 125-61.
5. Portha B, Blondel O, Serradas P, McEvoy R, Giroix M-H, Kergoat M et al. The rat models of non-insulin dependent diabetes induced by neonatal streptozotocin. Diabete Metab 1989; 15: 61-75.
6. Klöppel G, Löhr M, Hablich K, Oberholzer M, Heitz PU. Islet pathology and pathogenesis of type 1 and type 2 diabetes mellitus revisited. Sur Synth Path Res 1985; 4: 110-25.
7. Lazarow A. Spontaneous recovery from alloxan diabetes in rats. Diabetes 1952; 1: 363-70.
8. Montana E, Bonner-Weir S, Weir GC. Transplanted beta cell response to increased metabolic demand. Changes in beta cell replication and mass. J Clin Invest 1994; 93: 1577-82.
9. Weir GC, Bonner-Weir S, Leahy JL. Islet mass and function in diabetes and transplantation. Diabetes 1990; 39: 401-5.
10. Korsgren O, Jansson L, Sandler S, Andersson A. Hyperglycaemia-induced β-cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background. J Clin Invest 1990; 86: 2161-8.
11. Korsgren O, Andersson A, Sandler S. Pretreatment of foetal porcine pancreas in culture with nicotinamide accelerates reversal of diabetes after transplantation to nude mice. Surgery 1993; 113: 205-14.
12. Korc M. Editorial. Islet growth factors: Curing diabetes and preventing chronic pancreatitis? J Clin Invest 1993; 92: 1113-14.
13. Sjöholm Å. Intracellular signal transduction pathways that control pancreatic β-cell proliferation. FEBS Lett 1992; 311: 85-90.
14. Sjöholm Å. Invited review. Role of polyamines in the regulation of proliferation and hormone production by insulin-secreting cells. Am J Physiol 1993; 264: C501-18.
15. Welsh M, Mares J, Öberg C, Karlsson T. Genetic factors of importance for β-cell proliferation. Diabetes Metab Rev 1993; 9: 25-36.
16. Rosenberg L, Clas D, Duguid WP. Trophic stimulation of the ductal/islet cell axis: a new approach to the treatment of diabetes. Surgery 1990; 108: 191-7.
17. Rosenberg L, Duguid WP, Brown RA, Vinik AI. Induction of nesidioblastosis will reverse diabetes in Syrian gold hamster. Diabetes 1988; 37: 334-41.
18. Vinik AI, Pittenger G, Rafaeloff R, Rosenberg L. Factors controlling pancreatic islet neogenesis. Tumour Biol 1993; 14: 184-200.
19. Rosenberg L, Vinik AI. Trophic stimulation of the ducturalislet cell axis: a new approach to the treatment of diabetes. In: Vinik AI, ed. Pancreatic Islet Cell Regeneration and Growth. New York, NY: Plenum Press, 1992; pp. 95-104.
20. Efendić S, Luft R, Wajngot A. Aspects of the pathogenesis of type 2 diabetes. In: Boström H. Ljungstedt N, eds. Recent Trends in Diabetes Research. Stockholm: Almqvist and Wiksell, 1981; pp. 75-84.
21. Westermark P, Wilander E. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 1978; 15: 417-21.
22. Docherty K, Clark AR. Nutrient regulation of insulin gene expression. FASEB J 1994; 8: 20-7.
23. Halban PA. Proinsulin trafficking and processing in the pancreatic β-cell. Trends Endocrinol Metab 1990; 1: 261-5.
24. Howell SL, Bird GSJ. Biosynthesis and secretion of insulin. Br Med Bull 1989; 45: 19-36.
25. Welsh M. Glucose regulation of insulin gene expression. Diabéte Metab 1989; 15: 367-71.
26. Hedeskov CJ. Mechanisms of glucose-induced insulin secretion. Physiol Rev 1980; 60: 442-508.
27. Meglasson MD, Matschinsky FM. Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes/Metab Rev 1986; 2: 163-214.
28. Sharp GWG. The adenylate cyclase-cyclic AMP system in the islets of Langerhans and its role in the control of insulin release. Diabetologia 1979; 16: 287-96.
29. Metz SA. Is protein kinase C required for physiologic insulin release? Diabetes 1988; 37: 3-7.
30. Wollheim CB, Sharp GWG. Regulation of insulin release by calcium. Physiol Rev 1981; 61: 914-73.
31. Wollheim CB, Regazzi R. Protein kinase C in insulin releasing cells. Putative role in stimulus secretion coupling. FEBS Lett 1990; 268: 376-80.
32. + channels and diabetes mellitus. News Physiol Sci 1990; 5: 143-7.
33. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 1993; 361: 315-25.
34. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988; 334: 661-5.
35. 2+ channels. J Biol Chem 1994; 269: 2743-9.
36. Ämmälä C, Eliasson L, Bokvist K, Berggren P-O, Honkanen RE, Sjöholm Å et al. Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in the pancreatic β-cells. Proc Natl Acad Sci USA 1994; 91: 4343-7.
37. Sjöholm Å. Phorbol ester stimulation of pancreatic β-cell replication, polyamine content and insulin secretion. FEBS Lett 1991; 294: 257-60.
38. Miller RE. Pancreatic neuroendocrinology: peripheral neural mechanisms in the regulation of the islets of Langerhans. Endocrine Rev 1981; 2: 471-94.
39. Smith PH, Porte D Jr. Neuropharmacology of the pancreatic islets. Ann Rev Pharm Toxicol 1976; 16: 269-85.
40. 2+, inositol phosphate generation and phorbol ester sensitivity. J Clin Invest 1993; 92: 1910-17.
41. Swenne I. Effects of aging on the regenerative capacity of the pancreatic β-cell of the rat. Diabetes 1983; 32: 14-19.
42. Tejning S. Dietary factors and quantitative morphology of the islets of Langerhans. Act Med Scand 1947; 128 (Suppl. 198): 1-154.
43. Westman S. Development of the obese-hyperglycaemic syndrome in mice. Diabetologia 1968; 4: 141-9.
44. Bonner-Weir S, Deanna D, Leahy JL, Weir GC. Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion. Diabetes 1989; 38: 49-53.
45. Dunger A-M, Sjöholm Å, Eizirik DL. Amino acids and human amniotic fluid increase DNA biosynthesis in pancreatic islets of adult mice, but this effect is lost following exposure to streptozotocin. Pancreas 1990; 5: 639-46.
46. Milner RDG, Wirdnam PK. The pancreatic β-cell fraction in children with errors of amino acid metabolism. Pediatr Res 1982; 16: 213-16.
47. Salata R, Klein I. Effects of lithium on the endocrine system: a review. J Lab Clin Med 1987; 110: 130-42.
48. Rossetti L. Normalization of insulin sensitivity with lithium in diabetic rats. Diabetes 1989; 38: 648-54.
49. Weiss H. Ueber eine neue Behandlungsmethode des Diabetes Mellitus und verwandter Stoffwechselstörungen. Wien Klin Wochenschr 1924; 37: 1142-3.
50. Sjöholra Å, Welsh N. Hellerström C. Lithium increases DNA replication, polyamine content and insulin secretion by rat pancreatic β-cells. Am J Physiol 1992; 262: C391-5.
51. Sjöholm Å, Welsh N, Sandler S, Hellerström C. Role of polyamines in mitogenic and secretory responses of pancreatic β-cells to growth factors. Am J Physiol 1990; 259: C828-33.
52. Sjöholm Å, Hellerström C. TGF-β stimulates insulin secretion and blocks mitogenic response of pancreatic β-cells to glucose. Am J Physiol 1991; 260: C1046-51.
53. Sjöholm Å, Funakoshi A, Efendić S, Östenson C-G, Hellerström C. Long-term inhibitory effects of pancreastatin and diazepam binding inhibitor on pancreatic β-cell deoxyribonucleic acid replication, polyamine content, and insulin secretion. Endocrinology 1991; 128: 3277-82.
54. Sjöholm Å. Differential effects of cytokines on long-term mitogenic and secretory responses of foetal rat pancreatic β-cells. Am J Physiol 1992; 263: C114-20.
55. Billestrup N, Nielsen JH. The stimulatory effect of growth hormone, prolactin, and placental lactogen on β-cell proliferation is not mediated by insulin-like growth factor I. Endocrinology 1991; 129: 883-8.
56. Swenne I, Hill DJ, Strain AJ, Milner RDG. Growth hormone regulation of somatomedin C/insulin-like growth factor I production and DNA replication in foetal rat islets in tissue culture. Diabetes 1987; 36: 288-94.
57. Chen Z, Agerberth B, Gell K, Andersson M, Mutt V. Östenson C-G et al. Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. Eur J Biochem 1988; 174: 239-45.
58. Tatemoto K, Efendić S, Mutt V, Makk G, Feistner GJ. Barchas JD. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 1986; 324: 476-8.
59. Efendić S, Tatemoto K, Mutt V, Quan C, Chang D, Östenson C-G. Pancreastatin and islet hormone release. Proc Natl Acad Sci USA 1987; 84: 7257-60.
60. Smith FE, Rosen KM, Villa-Komaroff L, Weir G, Bonner-Weir S. Enhanced insulin-like growth factor I gene expression in regenerating rat pancreas. Proc Natl Acad Sci USA 1991; 88: 6152-6.
61. Warnock GL, Rajotte RV. Critical mass of purified islets that induce normoglycaemia after implantation into dogs. Diabetes 1988; 37: 467-70.
62. Eisenbarth GS. Type I diabetes mellitus: a chronic autoimmune disease. New Engl J Med 1986; 314: 1360-8.
63. Jiang Z, Woda BA. Cytokine gene expression in the islets of the diabetic biobreeding/Worcester rat. J Immunol 1991; 146: 2990-4.
64. Bendtzen K. Immune hormones (cytokines); pathogenic role in autoimmune rheumatic and endocrine diseases. Autoimmunity 1989; 2: 177-89.
65. Hussain MJ, Peakman M, Leslie RDG, Viberti GC, Watkins PJ, Vergani D. Circulating levels of interleukin 1α, tumour necrosis factor-α and interferon-γ are high in newly-diagnosed insulin-dependent diabetes. Diabetic Med 1990; 7 (Suppl. 1): 2A.
66. Corbett JA, McDaniel ML. Intraislet release of interleukin-1 inhibits β-cell function by inducing β-cell expression of inducible nitric oxide synthase. J Exp Med 1995; 181: 559-68.
67. Sjöholm Å. Inhibition of foetal rat pancreatic β-cell replication by interleukin-β in vitro is not mediated through pertussis toxin-sensitive G-protein, a decrease in cyclic AMP. or protease activation. FEBS Lett 1991; 289: 249-52.
68. Sjöholm Å. Cytokines inhibit rat insulinoma cell proliferation and insulin secretion non-synergistically and in a pertussis toxin-insensitive manner. Immunol Lett 1991; 30: 81-6.
69. Mares J, Welsh M. Expression of certain antiproliferative and growth-related genes in isolated mouse pancreatic islets: analysis by polymerase chain reaction. Diabete Metab 1993; 19: 315-20.
70. Reaven EP, Gold G, Reaven GM. Effect of age on glucose-stimulated insulin release by the β-cell of the rat. J Clin Invest 1979; 64: 591-9.
71. Swenne I, Andersson A. Effect of genetic background on the capacity for islet cell replication in mice. Diabetologia 1984; 27: 464-7.
72. Yonemura Y, Takashima T, Miwa K, Miyazaki H, Yamamoto H, Okamoto H. Amelioration of diabetes mellitus in partially depancreatized rats by poly(ADP-ribose)synthetase inhibitors: evidence of islet cell regeneration. Diabetes 1984; 33: 401-4.
73. Vague P, Vialettes B, Lassman-Vague V, Vallo JJ. Nicotinamide may extend remission phase in insulin-dependent diabetes. Lancet 1987; i: 619.
74. Sandler S, Andersson A. Stimulation of cell replication in transplanted pancreatic islets by nicotinamide treatment. Transplantation 1988; 46: 30-1.
75. Otonkoski T, Beattie GM, Mally ML, Ricordi T, Hayek A. Nicotinamide is a potent inducer of endocrine differentiation in cultured human foetal pancreatic cells. J Clin Invest 1993; 92: 1459-66.
76. Sjöholm Å, Korsgren O, Anderson A. Polyamine requirements in nicotinamide-stimulated β-cell differentiation in foetal porcine islet-like cell clusters. Endocrinology 1994; 135: 1559-65.
77. Sjöholm Å. Inhibitory effects of cyclosporin A on rat insulinoma cell proliferation, polyamine content and insulin secretion. Mol Cell Endocrinol 1994; 99: 21-4.
78. Thorens B, Waeber G. Glucagon-like peptide I and the control of insulin secretion in the normal state and in NIDDM. Diabetes 1993; 42: 1219-25.
79. Ørskov C. Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia 1992; 35: 701-11.
80. Gutniak MK, Ørskov C, Holst JJ, Ahrén B, Efendić S. Antidiabetogenic effect of glucagon-like peptide 1 (7-36)amide in normal subjects and in patients with diabetes mellitus. New Engl J Med 1992; 326: 1316-22.
81. Gutniak MK, Linde B, Holst JJ, Efendić S. Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycaemia in NIDDM. Diabetes Care 1994; 17: 1059-44.
82. Holz GG, Kühtreiber WM, Habener JF. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1 (7-37). Nature 1993; 361: 362-5.
83. Sjöholm Å. α-Adrenergic inhibition of rat pancreatic β-cell replication and insulin secretion is mediated through a pertussis toxin-sensitive G-protein regulating islet cAMP content. Biochem Biophys Res Commun 1991; 180: 152-5.
84. Gu D, Sarvetnick N. Epithelial cell proliferation and islet neogenesis in IFN-γ transgenic mice. Development 1993; 118: 33-46.
85. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990; 61: 1137-46.
86. Wang TC, Bonner-Weir S, Oates PS, Chulak MB, Simon B, Merlino GT et al. Pancreatic gastrin stimulates islet differentiation of transforming growth factor α-induced ductular precursor cells. J Clin Invest 1993; 92: 1349-56.
87. Mansfeld G. Versuche zu einer operativen behandlung des diabetes. Klin Wochenscr 1927; 6: 1-8.